[THYROTOXIC STATE IN A SUBJECT WITH METASTASIZED THYROID NEOPLASM].
D000230:Adenocarcinoma; D013956:Antithyroid Agents; D001859:Bone Neoplasms; D003036:Cobalt Isotopes; D006980:Hyperthyroidism; D007456:Iodine Isotopes / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D010386:Pelvic Neoplasms; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012272:Ribs; D013960:Thyroid Function Tests; D013964:Thyroid Neoplasms
D013956:Antithyroid Agents; D003036:Cobalt Isotopes; D007456:Iodine Isotopes; D011868:Radioisotopes
ADENOCARCINOMA; BONE NEOPLASMS; COBALT ISOTOPES; HYPERTHYROIDISM; IODINE ISOTOPES, DIAGNOSTIC; IODINE ISOTOPES, THERAPEUTIC; NEOPLASM DIAGNOSIS; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; PELVIC NEOPLASMS; RADIOISOTOPE SCANNING; RIBS; THYROID ANTAGONISTS; THYROID GLAND FUNCTION TESTS; THYROID NEOPLASMS
STATO TIREOTOSSICO IN UN PORTATORE DI NEOPLASIA TIROIDEA METASTATIZZATA.